Biossil

Seed
biossil.co Biotech & Healthcare Toronto, Canada 11-50
Total Funding $156.7M
Latest Round $153M Seed
Last Announced Sep 28, 2026
Investors 9 Backers
Decision Makers Profile Active

About Biossil

Biossil is an AI native biopharma company that advances late-stage programs for life-threatening diseases. It uses an applied AI drug discovery platform to create specialized treatments for distinct patients. Biossil brings resuscitated drugs to market and expands its capacity for clinical development.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Toronto, Canada
Team Size 11-50
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website biossil.co
Domain Registered Date May 21, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $153,000,000 · Venture Round

    The Globe and Mail

  2. Capital Raise

    Raised $3,700,000 · Seed

    fundraisingfox.com

  3. Milestone

    Website domain registered

    biossil.co

Investors & Backers

9
Abu Dhabi Investment Council
Duke University
Founders Fund
Golden Ventures
Modern Capital
OpenAI Startup Fund
Panache Ventures
Quiet Capital
Staircase Ventures

Funding History

2 Rounds
Venture Round · Sep 28, 2026
Seed · Apr 20, 2026

Founders & Leadership

2

Anthony Mouchantaf

Chief Executive Officer

Work email & phone locked Unlock →

Kevin Kuo

Head of Medical

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts